The technology investment arm of Albion Capital Group has partnered with the district to give startups the clinical application they need to grow.
AlbionVC, the technology investment arm of Albion Capital Group, has partnered with Harley Street Health District to expand access to transformative technologies and accelerate the adoption of new models of care in the UK.
The London-based venture capital fund, which has around £1 billion in assets under management, plans to offer startups a structured pathway to engage with the private sector, allowing them to co-develop, pilot, gather essential clinical evidence and scale innovations in a real-world clinical setting.
The firm said that the model brings scale to what AlbionVC-backed companies, such as pain management firm Pastel Health and healthcare platform integration firm Evaro, have already demonstrated, and creates a formalised pathway for founders to validate and scale their technology.
“We see incredible healthcare innovation in the UK, but the hardest part is always the same: getting it into the hands of clinicians who can actually use it,” said AlbionVC’s deputy managing partner Andrew Elder
“That’s why this partnership is exciting. It bridges the gap between the technology and the clinic. We’re not just funding companies, we’re connecting them to the world-renowned expertise of Harley Street Health District, which gives them the clinical application they need to prove their value and improve patient lives immediately.”
Faster care delivery
While focused on the private sector, the partnership aims to benefit the wider UK healthcare ecosystem, including the NHS. With growing numbers of people opting for private healthcare in the UK, a blended model of healthcare is emerging as patients increasingly navigate both systems. With more than 2,500 consultants working across both providers in Harley Street Health District and the NHS, and five NHS-run private patient units located in the Harley Street Health District, successful pilots in the private sector can speed up the evaluation pathways required for national adoption.
“By coupling [Harley Street Health District’s] agility with access to high-quality healthtech startups, we’re enabling a faster, more responsive era of care delivery. London’s health innovation triangle brings together world-leading research and clinical expertise, and this partnership leverages that strength to accelerate the best clinical innovations into practice,” said Jenny Shand, healthcare advisor for Harley Street Health District and professor of Applied Health Research at UCL.
In April, after £52 million investment, Hale House was developed in the Harley Street Health District to be a hub for healthtech. And in the summer, independent healthcare provider Phoenix Hospital Group opened a new memory clinic within the Harley Street Health District, which offers a full cognitive assessment and diagnosis.
